Technology
Researchers engineer “Nanotraps” that block SARS-CoV-2 infection – News-Medical.Net
Researchers at Chicago University have developed an innovative new anti-SARS-CoV-2 therapy called “Nanotraps” – a family of nano-enabled virus-trapping particles…
It is well known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, invades the human host cell through its spike protein. This protein engages with the angiotensin-converting enzyme 2 (ACE2) receptors on the human cell, enabling the virus to infiltrate and hijack its metabolic mechanisms for the purposes of viral replication.
A new nanomedicine, called “Nanotraps” – a family of nano-enabled virus-trapping…
-
General18 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business22 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Business20 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025